Find the Perfect Plan for Your Investment Journey
Last Price
52 Week Range
$6.50 - $25.67
Next Earnings Date
May 08 2025
Next Earnings Date
May 08 2025
Last Price
Market Cap | $5.75B |
EV | $5.73B |
Shares Outstanding | 243.79M |
Beta | 0.53 |
Analyst Rating | BUY |
Analyst Target Price | $25.74 |
P/E 2025E | 36.26x |
P/Revenue 2025E | 11.60x |
Revenue | 74.00% |
EPS | - |
Operating Cash Flow | - |
Free Cash Flow | - |
Revenue | 21.70% |
EPS | 12.70% |
Operating Cash Flow | 35.70% |
Free Cash Flow | 33.50% |
Gross Margin 2025E | 55.63% |
Net Profit Margin 2025E | 33.02% |
ROE 2025E | - |
ROCE 2024 | 81.65% |
DPS 2025E | - |
Payout Ratio 2025E | - |
Div. Yield 2025E | - |
DPS Last 3Y CAGR | - |
Price
%
1M
3M
6M
1Y
3Y
5Y
ADMA Biologics, Inc.
ADMA
Sector
Healthcare
Industry
Biotechnology
CEO
Grossman, Adam
Employees
685
Website
www.admabiologics.comIPO Date
2013-10-17
Headquarters
465 State Route 17, Ramsey, New Jersey, 07446, United States
COMPANY
NEWSLETTER
© Copyright 2025, All Rights Reserved